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Abstract
Traumatic brain injury (TBI) victims are considered to be at high risk for infection. The purpose of this cohort study was to delineate
the rates, types and risk factors for infection in TBI patients. Retrospective surveillance of infections was conducted for all TBI patients,
aged ‡18 years, cared for at the Department of Neurosurgery of the University Hospital of Heraklion, Greece, between 1999 and
2005. A total of 760 patients (75% men) with a median age of 41 years were included. Most (59%) were injured in a motor vehicle acci-
dent. One third of them underwent a surgical procedure. Two hundred and fourteen infections were observed. The majority were
infections of the lower respiratory tract (47%), followed by surgical site infections (SSI) (17%). Multivariate analysis showed that SSI
development was independently associated with the performance of ‡2 surgical procedures (OR 16.7), presence of concomitant infec-
tions, namely VAP (OR 5.7) and UTI (OR 8.8), insertion of lumbar (OR 34.5) and ventricular drains (OR 4.0), and cerebrospinal fluid
(CSF) leak (OR 3.8). Development of meningitis was associated with prolonged hospitalization (OR 1.02), especially >7 days ICU stay
(OR 25.5), and insertion of lumbar (OR 297) and ventricular drains (OR 9.1). There was a notable predominance of Acinetobacter spp.
as a VAP pathogen; gram-positive organisms remained the most prevalent in SSI cases. Respiratory tract infections were the most com-
mon among TBI patients. Device-related communication of the CSF with the environment and prolonged hospitalization, especially in
the ICU setting, were independent risk factors for SSIs and meningitis cases.
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Introduction
Patients with traumatic brain injury (TBI) are considered to
be at higher risk for nosocomial infections compared with
other critically ill individuals and other neurosurgical patients
[1,2]. Infection-related mortality rates may be as high as 28%
[3]. Despite the significant financial burden [4] and loss of life
associated with these infections, few studies have investi-
gated the risk factors for development of infections in TBI
patients. To this end, we conducted a retrospective cohort
study to further define the risk factors and microbiology of
infections in this population.
Materials and Methods
Identification of patients and data collection
Patients ‡18 years old, admitted for TBI to the Department
of Neurosurgery of University Hospital of Heraklion,
Greece, during the years 1999–2005 were included. Medical
records were surveyed retrospectively for the development
ª2011 The Authors
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE INFECTIOUS DISEASES
of surgical site infections (SSIs), including meningitis and
infections outside the surgical field.
Data were collected according to a standard form. The
presence of any co-morbid conditions, the type of procedure
performed, implantation of foreign bodies, procedure
urgency, duration of surgery, concomitant procedures, inten-
sive care unit (ICU) stay, presence of any drain, re-opera-
tions and CSF leaks were recorded. The CSF leak was
recorded when such drainage was diagnosed before or after
surgery on the basis of otorrhea, rhinorrhea or leakage from
the surgical wound. Infections were determined according to
the definitions of the Centers for Disease Control/National
Healthcare Safety Network (CDC/NHSN) [5]. A surgical site
infection (SSI) was defined as (i) purulent drainage superfi-
cially or deeply from the incision or from the organ/space,
(ii) organisms isolated from aseptically obtained fluid or tis-
sue culture, (iii) symptoms and signs of an infection and (iv)
diagnosis of a superficial or deep-seated SSI made by the sur-
geon or the attending physician. Meningitis was diagnosed if
(i) organisms were cultured from the cerebrospinal fluid
(CSF) and (ii) diagnosis was made by the attending physician
with at least one of the following: increased white cells, ele-
vated protein or decreased glucose on CSF examination,
organisms seen on Gram stain of CSF, organisms cultured
from blood or positive antigen test of CSF, blood or urine.
Statistical analysis
Data were analysed using SPSS software (version 16.0; SPSS
Inc., Chicago, IL, USA). Continuous variables were compared
using Student’s t-test or the Mann–Whitney U-test, whereas
categorical variables were compared using Fisher’s exact test.
In univariate analysis, odds ratios (ORs) and 95% confidence
intervals (95% CI) were calculated using the Mantel–Haenszel
statistic. Stepwise multivariate logistic regression was then
used to model the interactions of those variables significantly
associated with SSIs or meningitis in univariate analyses. A
backward elimination model was used with Penter = 0.20 and
Pleave = 0.05 to identify independent predictors for SSI and
meningitis. Power calculations were performed using the
PASS software (PASS 2008, http://www.ncss.com/pass.html).
Results
Study population
Seven hundred and sixty patients (75.4% men) were studied.
Causes of TBIs included motor vehicle accidents (58.9%), fall
(36.5%) and assault (2.8%). The median age was 41 (range,
18–96) years. Two hundred and fifty-eight patients (33.3% of
TBI admissions) underwent a total of 342 surgical proce-
dures. Fifty-three patients (20.5%) had at least two proce-
dures performed (range, 2–8). Younger patients had a
greater chance of undergoing ‡2 procedures (p <0.001). The
most common procedure performed was burr-hole (29.2%),
with craniotomy a close second (28.9%). The median length
of hospitalization was 7 days (range, 0–249) and the median
length of stay (LOS) before the procedures were performed
was 1 day (range, 0–136). The LOS was significantly higher in
patients who developed SSIs in general and meningitis in par-
ticular (p <0.001).
Fifty-three of the TBI admissions (6.3%) were complicated
with at least one SSI, superficial or deep-seated. The most
common SSI was wound infection (2.2%), followed by menin-
gitis/ventriculitis (2.0%). However, shunt infections (0.8%),
bone flap/osteomyelitis or Palacos infections (0.4%),
abscesses (0.1%) and epidural empyemas (0.2%) were extre-
mely rare. The rate of SSIs expressed in infections/1000
patient-days were 2.79/1000 patient-days. The rate of menin-
gitis was 1.13/1000 patient-days.
The total fatality rate in the present cohort was 8.3% (5%
for the patients that did not undergo neurosurgery and
12.8% for patients who did). The difference was statistically
significant (OR, 2.8; CI, 1.65–4.8). Development of SSIs was
associated with increased adverse final outcomes (OR, 2.9
(1.3–6.6); p 0.016). Meningitis was not associated with
increased adverse final outcomes (OR, 2.42 (0.68–8.66);
p 0.16) Among the total number of infections encountered,
ventilator-associated pneumonia (VAP) was the most com-
mon (33.2%), with surgical site infections (SSIs) (17%), urine
tract infections (UTIs) (15.4%), pneumonia (14.0%), catheter-
associated bacteraemias/blood stream infections (CAB/BSI)
(10.7%) and meningitis following (7.9%). The infection rates,
expressed in number/1000 patient-days were 4.71 VAP/1000
patient-days, 2.2 UTI/1000 patient-days and 1.5 bacteraemias/
1000 patient-days.
The median duration of surgery was 2 h (range, 0.5–4.5).
In 23% of the patients there was insertion of some kind of
drain and 14.8% had intraparenchymal Camino intracranial
pressure monitoring (ICP) (Camino Laboratories, San Diego,
CA, USA) or a Codman MicroSensor (Johnson and Johnson
Medical Ltd, Raynham, MA, USA) catheter inserted.
Infection risk, rates and microbiology
Several variables were examined for their contribution to
the risk of SSI development, both superficial and deep-
seated, including meningitis. TBI patients who underwent
neurosurgery had an OR of 25.0 (95% CI, 3.3–189.6) for
developing meningitis compared with patients who did not.
The median time between the surgery and the meningitis
diagnosis was 7 days (range, 2–41).
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Among the 194 cases with a drain, 13.4% developed
an SSI and 6.7% developed meningitis. The risk of SSIs and
meningitis increased by days of CSF drainage (Figs 1 and 2,
respectively).
A low admission Glasgow Coma Scale (GCS) score was
significantly correlated with a longer length of stay (LOS)
(p <0.0001), an adverse final outcome (p <0.0001), a low
Glasgow Outcome Scale (GOS) score (p <0.0001) and a
greater propensity for development of infections. The TBI
patients who underwent neurosurgery had a significantly
lower admission GCS, and were more prone to be intubated
and be admitted to the Intensive Care Unit. They were also
more prone to develop meningitis, SSI and other concomi-
tant infections and had increased mortality (Table 1). The
characteristics of the TBI patients who developed and did
not develop any infectious complication are shown in
Table 2.
Multivariate analysis showed that independent risk factors
for SSI included the performance of ‡2 surgical procedures
(OR, 16.7; p <0.001), the insertion of lumbar (OR, 34.5;
p 0.002) and marginally of ventricular drains (OR, 4.0;
p 0.05), the presence of concomitant infections, namely UTI
(OR, 8.8; p 0.001) and VAP (OR, 5.7; p 0.004), and margin-
ally CSF leak (OR, 3.8; p 0.05). Independent risk factors for
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FIG. 1. Risk for surgical site infection by days of CSF drain.
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FIG. 2. Risk for meningitis by days of CSF drain.
TABLE 1. Comparison of the baseline characteristics, the infectious complications, the perioperative characteristics and the
outcome between patients who did and did not undergo neurosurgery
Feature
Surgery
(rate at risk
group or
mean ± SD)
Non-surgery
(rate at risk
group or
mean ± SD)
Odds ratio
(95% CI) p value
Gender (female) 24.0 25.2 0.93 (0.68–1.28) 0.674
Age (years) 47.8 ± 25.1 44.2 ± 22.0 0.029
Co-morbidities
Diabetes mellitus 7.9 4.1 2.0 (1.11–3.60) 0.021
Malignancy 2.6 1.0 2.74 (0.91–8.23) 0.074
ASCVD 8.2 5.7 1.48 (0.87–2.54) 0.152
CRF 1.5 0.2 7.57 (0.88–65.1) 0.065
Steroid use 0.3 0.2 1.50 (0.09–24.0) 0.776
Meningitis development 4.7 0.2 25 (3.3–189.6) <0.001
Surgical site infection development 10.5 1.18 9.9 (4.12–23.77) <0.001
Concomitant infections 22.2 9.2 2.82 (1.9–4.2) <0.001
VAP 12.9 5.3 2.65 (1.6–4.36) <0.001
Pneumonia 5.6 2.2 2.67 (1.25–5.69) 0.012
CAB/BSI 5 1.2 4.4 (1.72–11.28) 0.001
UTI 6.7 2.0 3.61 (1.7–7.69) 0.001
Admission GCS score 11.3 ± 3.9 12.9 ± 2.9 <0.001
Intubation 29.8 12.3 3.02 (2.12–4.29) <0.001
Tracheostomy 15.2 6.5 2.60 (1.64–4.11) <0.001
Intracranial pressure monitoring (ICP) 24.9 8 3.79 (2.53–5.67) <0.001
ICP days 6.0 ± 3.9 5.9 ± 3.3 17.5 (4.09–74.91) 0.97
Ventricular drain 6.4 4 <0.001
Lumbar drain 2.3 2 12.22 (1.52–98.1) 0.004
Drain days 3.5 ± 4.8 4.0 ± 2.8 0.883
ICU stay 44.4 18.4 <0.001
ICU days 11.6 ± 13.4 8.1 ± 7.6 3.55 (2.60–4.83) 0.055
Brain protection protocol 7 2.5 0.003
Length of stay (days) 31.2 ± 44.4 8.7 ± 11.5 2.89 (1.45–5.76) <0.001
Adverse final outcome 12.8 5 2.8 (1.65–4.8) <0.001
ASCVD, atherosclerotic cardiovascular disease; CRD, chronic renal disease; VAP, ventilator-associated pneumonia; UTI, urine tract infection; CAB-BSI, catheter-associated
bacteraemia blood stream infections; GCS, Glasgow Coma Scale; ICU, intensive care unit.
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meningitis included the prolonged length of stay (p <0.001),
the ICU stay when prolonged for >7 days (OR, 25.5;
p 0.009) and only marginally for £7 days (OR, 10.5; p 0.054)
and the insertion of lumbar (OR, 296.9; p <0.001) and ven-
tricular drains (OR, 9.1; p 0.017; Table 3).
The microbiological samples were processed using stan-
dard laboratory protocols. The bacterial pathogens were
identified by conventional biochemical methods, the API sys-
tems (BioMerieux, Marcy L’ Etoile, France) or the automated
system Vitek 2 (BioMerieux). Regarding the isolated patho-
gens, Acinetobacter spp. were the predominant pathogens in
respiratory tract infections (Acinetobacter baumanii predomi-
nated), with S. aureus being second. In SSI and meningitis/
ventriculitis gram-positive pathogens predominated. The
pathogens isolated from the various infections are demon-
strated in Table 4.
Discussion
The purpose of this investigation was to determine the rates,
bacteriology and risk factors associated with infection in TBI
patients. The most common sites of infection in our centre
were similar to those previously reported in TBI patients [1]
and in trauma patients in general [6]. We noticed a predomi-
nance of Acinetobacter spp. in respiratory tract infections in
TABLE 2. Characteristics of traumatic
brain injury patients who did or did not
develop an infectious complication
Feature No infection Infection Odds ratio (95% CI) p value
Gender (female) 25.3 21.8 0.82 (0.54–1.27) 0.380
Age (years) 46.3 ± 23.5 41.9 ± 22.1 – 0.041
Co-morbidities
Diabetes mellitus 5.3 7.0 1.34 (0.65–2.76) 0.424
Malignancy 1.1 4.2 3.88 (1.32–11.3) 0.013
ASCVD 6.5 7.7 1.21 (0.61–2.41) 0.579
CRF 0.8 0.0 – –
Steroid use 0.3 0.0 – –
Length of stay (days) 10.6 ± 18.9 53.7 ± 51.3 – <0.001
ICU (days) 6.5 ± 8.1 15.2 ± 13.7 – <0.001
Drain days 2.4 ± 3.1 5.2 ± 6.4 – 0.005
ICP duration (days) 4.4 ± 3.0 6.8 ± 3.8 – 0.027
Admission GCS 12.9 ± 3.0 9.1 ± 3.6 – <0.001
Intubation 11.8 57.0 9.91 (6.63–14.83) <0.001
Tracheotomy 4.9 35.2 10.50 (6.47–17) <0.001
ICU stay 19.8 73.9 11.47 (7.56–17.4) <0.001
Brain protection protocol 2.3 14.8 7.54 (3.83–14.86) <0.001
ICP presence 7.3 52.1 13.79 (8.94–21.3) <0.001
Any drain 20.0 43.0 3 (2.06–4.41) <0.001
Lumbar drain 0.3 4.9 18.38 (3.78–89.4) <0.001
Ventricular drain 1.5 9.2 6.41 (2.81–14.63) <0.001
Adverse outcome 7.0 14.4 2.23 (1.27–3.91) 0.005
Data are presented as percentages (categorical variables) or mean ± standard deviation (continuous variables).
OR, odds ratio; 95% CI, 95% confidence interval.
TABLE 3. Multivariate logistic regression for the factors
associated with the development of SSI and meningitis
Independent variables OR (95% CI)a p value
SSI (dependent)
Lumbar drain 34.5 (3.8–309.3) 0.002
Multiple procedures (‡2) 16.7 (5.4–51.8) <0.001
UTI 8.8 (2.3–33.7) 0.001
VAP 5.7 (1.7–18.0) 0.004
Ventricular drain 4.0 (1.0–16.3) 0.050
CSF leak 3.8 (1.0–14.2) 0.050
Meningitis (dependent)
Lumbar drain 296.9 (22.8–3864) <0.001
ICU stay
Stay £7 days (vs. no ICU) 10.5 (1.0–114.2) 0.054
Stay >7 days (vs. no ICU) 25.5 (2.3–286.7) 0.009
Ventricular drain 9.1 (1.5–55.5) 0.017
Length of stay (LOS) 1.02 (1.01–1.03) 0.001
aOdds ratio (95% confidence interval) for the independent variables associated
with the dependent outcome (SSI, meningitis). Logistic regression analysis (back-
wards elimination method) including independent variables significantly associ-
ated with the dependent outcomes in univariate analysis. Only statistically
significant associations are shown.
TABLE 4. Sites of infection and pathogenic bacteria most
commonly isolated in TBI patients
Infection site
Number of
infections (%) Organisms isolated (%)
Ventilator-associated
pneumonia (VAP)
71 (8.37) Acinetobacter spp. (38.0)
S. aureus (22.5)
P. aeruginosa (16.9),
H. influenzae (12.7)
Pneumonia 30 (3.54) Acinetobacter spp. (36.6)
S. aureus (26.7)
K. pneumoniae (20)
Urinary tract
infections (UTI)
33 (3.9) P. aeruginosa (27.2)
Candida spp. (24.2)
Enterococcus spp. (15)
Surgical site infections
(SSI) (other than meningitis)
36 (4.25) Coagulase ()) staphylococci
(CoNS) (28)
S. aureus (25)
P. aeruginosa (5.5)
Meningitis/ventriculitis 17 (2) CoNS (41.1)
Acinetobacter spp. (23.5)
Enterobacter spp.,
E. faecalis (5.9)
Catheter-associated
bacteraemia/blood
stream infections (CAB/BSI)
23 (2.7) CoNS (43.4)
Enterococcus spp. (26.1)
S. aureus (21.7)
Acinetobacter spp. (13)
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discordance with earlier reports [1,6–8]. The SSI rate is simi-
lar to that of previous reports in TBI individuals [1] and
higher than in the general neurosurgical population [9].
VAP was the most common infection in the present
cohort (8.4%), in accordance with previous studies
[1,3,10,11]. VAP development affected GOS score, but not
mortality, an observation also reported before [12]. The
main pathogens are shown in Table 3. Among them, Acineto-
bacter is an emergent microorganism. Interestingly, pneumo-
nia not associated with mechanical ventilation led to an
adverse final outcome, a finding previously unreported.
The percentage of CAB/BSI was 2.7%, lower than the 8%
reported in the literature [1], with a predominance of gram-
positive microorganisms (Table 3). UTIs were encountered
in 3.9%, in the range reported in the literature [1].
Superficial wound infections were the most common SSIs
in our population (2.2%) [1]. The rates of osteomyelitis,
abscess and empyema are comparable to or even lower than
those reported before [1]. The percentage of meningitis/
ventriculitis, which has always been considered a serious
complication of TBI [13,14], reached 2% in this cohort.
Baltas et al. [15] reported a 1.4% meningitis rate in a TBI
population, but in their cohort only 20% of the patients
underwent a surgical procedure. Gram-positive pathogens
represented 66.6% of the positive CSF cultures in our
patients. These results reflect their re-emergence as nosoco-
mial pathogens during the time period that the study was
performed [16,17]. The development of SSI marginally car-
ried an independent association with CSF leak, in agreement
with previous results [9]. The insertion of any drain was
associated with the development of both SSI and meningitis.
The duration of the drainage seemed to increase the risk of
SSIs, including meningitis, especially if the drainage exceeded
3 days. Although no definite conclusions can be drawn from
this observation, it would be prudent to suggest the earlier
removal of the drains when they are not needed.
The presence of lumbar and ventricular drains was an
independent risk factor for the development of both SSI in
general and meningitis in particular. Deep-seated infections
have not been extensively associated with the use of lumbar
drains [18,19]; their association with SSI other than meningi-
tis has not been previously reported. Ventricular drain place-
ment has repeatedly been associated with the development
of meningitis in prospective and retrospective studies
[16,20–26]. TBI has been associated with an increased risk of
ventriculostomy-related infections (VRI) in some [27] but
not all studies [23,24].
ICP placement and duration of ICP monitoring had no
effect on the SSI or meningitis development after the multi-
variate analysis. Concomitant infections remained an inde-
pendent risk factor for the development of SSI in this
cohort. Infections outside the surgical field have repeatedly
been regarded as risk factors for SSI development in the gen-
eral neurosurgical population but there is a paucity of data
regarding TBI patients [9,16,21,26]. The performance of ‡2
surgeries has been reported as an independent risk factor
for SSI (as in our cohort), and especially meningitis, in the
past [17,26].
ICU hospitalization was strongly associated with the
development of meningitis. The OR was 13.4 (p 0.03) but
when the ICU days were taken into account in the logistic
regression model, then ICU hospitalization for £7 days
approached statistical significance (OR 10.5) but admission
for >7 days was clearly independently associated with men-
ingitis development (OR 25.5). ICU hospitalization has
recently been associated with SSI development in our insti-
tution [28] but this is the first time that such an association
is being described in a TBI cohort. The total length of stay
(LOS) was independently associated with meningitis risk,
with a 2% increased risk for every day of hospitalization.
The associations of admission GCS score with LOS, final
outcome, GOS score and development of infections under-
line the significance of the initial clinical evaluation, as has
been described before [29].
A limitation of the study is that it is retrospective and
depended on the accuracy of the data in the clinical chart.
However, regarding its statistical power, the interesting point
is that the study had a power of 80% to detect a 2.5-fold
increase in risk, and 23% power to detect a 1.5-fold increase,
rendering it adequately powered to detect risk factors of
moderate-to-high strength. Nonetheless, the final regression
models with the independent risk factors were able to pre-
dict the risk for SSIs by 44% and the risk for meningitis by
51% (Nagelkerke R2 = 0.44 and 0.51, respectively).
Conclusions
The results of this study indicate that TBI patients are at a
high risk for developing infections. Respiratory tract infec-
tions were the most common in the cohort, with Acinetobac-
ter spp. being the impressive emerging pathogens. Meningitis
developed in 2% of the patients, whereas SSI other than
meningitis occurred in 4.25%. Device-related communication
of the CSF with the environment was a major risk factor for
the development of both SSI in general and meningitis in par-
ticular. The presence of CSF leak and infections outside the
surgical field should alert clinicians to SSI development in the
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TBI population. ICU stay, especially if prolonged for >7 days,
is for the first time confirmed as an independent risk factor
for meningitis development in head injury patients.
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